New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 18, 2014
06:17 EDTMJNMead Johnson risk/reward favorable into Q2 results, says Citigroup
Citigroup sees a favorble risk/reward for shares of Mead Johnson into the company's Q2 results saying its surveys indicate the company is seeing positive trends in its two largest markets of China and the U.S. Mead remains Citi's top pick in U.S. food with a Buy rating and $105 price target.
News For MJN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
07:55 EDTMJNMead Johnson management to meet with JPMorgan
Subscribe for More Information
07:39 EDTMJNMead Johnson sees FY15 EPS $3.63-$3.78, consensus $3.69
Subscribe for More Information
07:38 EDTMJNMead Johnson reports Q2 adjusted EPS 76c, consensus 77c
Reports Q2 revenue $1.03B, consensus $1.05B.
July 15, 2015
12:18 EDTMJNOn The Fly: Top stock stories at midday
Subscribe for More Information
11:44 EDTMJNMead Johnson volatility low, shares at one-year low after reducing 2015 guidance
Mead Johnson August call option implied volatility is at 26, November is at 23; compared to its 52-week range of 19 to 48; suggesting decreasing price movement after reducing fiscal 2015 EPS guidance.
11:08 EDTMJNFormula makers slip after Mead Johnson cuts guidance
Subscribe for More Information
10:09 EDTMJNMead Johnson falls, levels to watch
Subscribe for More Information
09:23 EDTMJNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Bank of America (BAC), up 2.9%... CSX (CSX), up 2.6%. ALSO HIGHER: Hertz (HTZ), up 3.9% after being upgraded to Buy from Hold at Deutsche Bank. NOTABLE: Receptos (RCPT), up 10.5% following deal to be acquired by Celgene (CELG)... Celgene is up 7.9% after announcing acquisition of Receptos... UP AFTER RECEPTOS/CELGENE DEAL: ZIOPHARM Oncology (ZIOP), up 1.7%... Arena Pharmaceuticals (ARNA), up 6.5%. DOWN AFTER EARNINGS: Delta Air Lines (DAL), down 2.4%. ALSO LOWER: Mead Johnson (MJN), down 4.8% after reducing fiscal 2015 EPS guidance... Columbia Pipeline Partners (CPPL), down 5.6% after 4.64M share Block Trade priced at $24.15... SINA (SINA), down 2.7% after being downgraded to Hold from Buy at Deutsche Bank... MacroGenics (MGNX), down 2.8% after 3.25M share Secondary priced at $37.00.
07:39 EDTMJNMead Johnson price target lowered to $89 from $99 at JPMorgan
Subscribe for More Information
July 14, 2015
19:05 EDTMJNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: CSX (CSX), up 3.5%. ALSO HIGHER: Receptos (RCPT), up 10.2% following deal to be acquired by Celgene (CELG)... Celgene is up 5.8% after announcing acquisition of Receptos... Celsion (CLSN), up 8.8% after being initiated with a Buy at BTIG... Aratana Therapeutics (PETX), up 10% after results of pivotal study of AT-003. DOWN AFTER EARNINGS: Peregrine (PPHM), down 3%... Yum! Brands (YUM), down marginally. ALSO LOWER: Allegheny Technologies (ATI), down 9.3% after providing second quarter EPS guidance... Mead Johnson (MJN), down 4.8% after reducing fiscal 2015 EPS guidance.
17:29 EDTMJNMead Johnson cuts FY15 adjusted EPS to $3.63-$3.78 from $3.90-$4.00
Mead Johnson announced that it is revising FY15 financial guidance based on preliminary Q2 sales results. Annual sales growth is expected to be in the range of 0%-2% on a constant-dollar basis, previously estimated at 7%. Including the estimated impact of foreign exchange, reported sales are expected to be 2% to 4% below the prior year, previously estimated to be 2% above the prior year. FY15 non-GAAP EPS is expected to be in the range of $3.63-$3.78, previously estimated at $3.90-$4.00. EPS consensus is $3.93. Specified items are currently expected to be 7c per share, excluding any future mark-to-market pension adjustment. As a result, full-year GAAP EPS guidance is expected to be in the range of $3.56-$3.71, previously estimated at $3.79-$3.89.
17:27 EDTMJNMead Johnson sees Q2 adjusted EPS 76c, consensus 89c
Mead Johnson Nutrition announced that preliminary Q2 constant dollar sales were 3% below the prior year quarter. Including the impact of foreign currency, preliminary reported sales were 7% below the prior year quarter. "Strong sales of the recently launched imported products to China were insufficient to fully offset declines in the China based manufactured products. Hong Kong cross-border sales stabilized, but were below prior year levels... Slowing emerging market growth and dairy costs approaching five-year lows drove competitive promotional price discounting across several markets in Latin America and Asia," said the company. Preliminary year-to-date sales were in-line with the prior year on a constant-dollar basis and 4% lower on a reported basis. Preliminary non-GAAP and GAAP EPS for Q2 are expected to be 76c and 80c, respectively. EPS consensus is 89c.
17:22 EDTMJNMead Johnson cuts FY15 guidance based on preliminary Q2 results

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use